CI
WST icon

Conning Inc’s West Pharmaceutical WST Stock Holding History

Conning Inc’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-566
Closed -$232K – 429
2022
Q1 		$232K Buy
566
+22
+4% +$8.61K 0.01% 393
2021
Q4 		$255K Buy
544
+37
+7% +$15.9K 0.01% 381
2021
Q3 		$215K Sell
507
-180
-26% -$75.9K 0.01% 420
2021
Q2 		$247K Sell
687
-88
-11% -$29.1K 0.01% 420
2021
Q1 		$218K Sell
775
-60
-7% -$17.2K 0.01% 449
2020
Q4 		$237K Buy
+835
New +$234K 0.01% 430

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Conning Inc's WST Position: Q2 2022 in Review

Conning Inc sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 566 shares — an estimated $232K sold.

Conning Inc first reported a position in WST in Q4 2020 and held it in 6 quarters. The position peaked at $255K in Q4 2021. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

  • Conning Inc reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Conning Inc sold 566 West Pharmaceutical shares in Q2 2022, an estimated $232K.
  • Conning Inc first reported a position in West Pharmaceutical in Q4 2020 and held it in 6 quarters.
  • Conning Inc's West Pharmaceutical position peaked at $255K in Q4 2021.
  • 655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Conning Inc's 13F filing for Q2 2022, filed 20 Jul 2022.